BDBM618052 N-(4-(1-(4-(5-(difluoromethyl)-1,3,4-oxadiazol-2-yl)benzyl)-1H-1,2,3-triazol-4-yl)phenyl)-4,5-dihydro-1H-imidazol-2-amine::US20230286970, Compound 10

SMILES FC(F)c1nnc(o1)-c1ccc(Cn2cc(nn2)-c2ccc(NC3=NCCN3)cc2)cc1

InChI Key InChIKey=TYHUIOMFTMEPGK-UHFFFAOYSA-N

Data  11 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 11 hits for monomerid = 618052   

TargetHistone deacetylase 6(Human)
Italfarmaco

US Patent
LigandPNGBDBM618052(US20230286970, Compound 10 | N-(4-(1-(4-(5-(difluo...)
Affinity DataIC50: 16nMAssay Description:For each test compound, 100× concentrated DMSO solutions at 8 doses were prepared and then diluted in assay buffer (25 mM Tris-HCl, pH 8, 130 mM NaCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetHistone deacetylase 8(Human)
Italfarmaco

US Patent
LigandPNGBDBM618052(US20230286970, Compound 10 | N-(4-(1-(4-(5-(difluo...)
Affinity DataIC50: 2.95E+4nMAssay Description:For each test compound, 100× concentrated DMSO solutions at 8 doses were prepared and then diluted in assay buffer (25 mM Tris-HCl, pH 8, 130 mM NaCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetHistone deacetylase 11(Human)
Italfarmaco

US Patent
LigandPNGBDBM618052(US20230286970, Compound 10 | N-(4-(1-(4-(5-(difluo...)
Affinity DataIC50: 3.00E+4nMAssay Description:For each test compound, 100× concentrated DMSO solutions at 8 doses were prepared and then diluted in assay buffer (25 mM Tris-HCl, pH 8, 130 mM NaCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetHistone deacetylase 7(Human)
Italfarmaco

US Patent
LigandPNGBDBM618052(US20230286970, Compound 10 | N-(4-(1-(4-(5-(difluo...)
Affinity DataIC50: 3.00E+4nMAssay Description:For each test compound, 100× concentrated DMSO solutions at 8 doses were prepared and then diluted in assay buffer (25 mM Tris-HCl, pH 8, 130 mM NaCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetHistone deacetylase 9(Human)
Italfarmaco

US Patent
LigandPNGBDBM618052(US20230286970, Compound 10 | N-(4-(1-(4-(5-(difluo...)
Affinity DataIC50: 3.00E+4nMAssay Description:For each test compound, 100× concentrated DMSO solutions at 8 doses were prepared and then diluted in assay buffer (25 mM Tris-HCl, pH 8, 130 mM NaCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetPolyamine deacetylase HDAC10(Human)
Italfarmaco

US Patent
LigandPNGBDBM618052(US20230286970, Compound 10 | N-(4-(1-(4-(5-(difluo...)
Affinity DataIC50: 3.00E+4nMAssay Description:For each test compound, 100× concentrated DMSO solutions at 8 doses were prepared and then diluted in assay buffer (25 mM Tris-HCl, pH 8, 130 mM NaCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Italfarmaco

US Patent
LigandPNGBDBM618052(US20230286970, Compound 10 | N-(4-(1-(4-(5-(difluo...)
Affinity DataIC50: 3.00E+4nMAssay Description:For each test compound, 100× concentrated DMSO solutions at 8 doses were prepared and then diluted in assay buffer (25 mM Tris-HCl, pH 8, 130 mM NaCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetHistone deacetylase 3(Human)
Italfarmaco

US Patent
LigandPNGBDBM618052(US20230286970, Compound 10 | N-(4-(1-(4-(5-(difluo...)
Affinity DataIC50: 3.00E+4nMAssay Description:For each test compound, 100× concentrated DMSO solutions at 8 doses were prepared and then diluted in assay buffer (25 mM Tris-HCl, pH 8, 130 mM NaCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetHistone deacetylase 4(Human)
Italfarmaco

US Patent
LigandPNGBDBM618052(US20230286970, Compound 10 | N-(4-(1-(4-(5-(difluo...)
Affinity DataIC50: 3.00E+4nMAssay Description:For each test compound, 100× concentrated DMSO solutions at 8 doses were prepared and then diluted in assay buffer (25 mM Tris-HCl, pH 8, 130 mM NaCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetHistone deacetylase 5(Human)
Italfarmaco

US Patent
LigandPNGBDBM618052(US20230286970, Compound 10 | N-(4-(1-(4-(5-(difluo...)
Affinity DataIC50: 3.00E+4nMAssay Description:For each test compound, 100× concentrated DMSO solutions at 8 doses were prepared and then diluted in assay buffer (25 mM Tris-HCl, pH 8, 130 mM NaCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Italfarmaco

US Patent
LigandPNGBDBM618052(US20230286970, Compound 10 | N-(4-(1-(4-(5-(difluo...)
Affinity DataIC50: 2.00E+5nMAssay Description:For each test compound, 100× concentrated DMSO solutions at 8 doses were prepared and then diluted in assay buffer (25 mM Tris-HCl, pH 8, 130 mM NaCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent